March 09, 2026

​​​​​​​PsA Treatment Options Expand

Phase 3 POETYK trial results support FDA approval of deucravacitinib for adults with active PsA.

Conexiant

March 09, 2026

CYP2D6 Testing and Postoperative Opioids

Investigators evaluate whether genotype-guided prescribing improves postoperative pain management.

Conexiant

March 06, 2026

Side Effects: Medicine's Blind Spot

Medicine is having a week: new insights on nutrition training, a rethink of “spring fatigue,” evidence that avocados may support artery health, and an AI that can spot rare hormone tumors from a hand photo

Conexiant

March 06, 2026

Weighted Vest in Obesity Trial

Daily standing and stepping time appeared to modify hip bone responses during dietary weight loss in a randomized trial

Conexiant

March 04, 2026

Exercise in Osteoarthritis: Does It Help?

Overview data on exercise therapy in osteoarthritis question its universal promotion

Conexiant

March 04, 2026

Spatial Proteomics Reveals Early Osteoarthritis Changes 

MALDI-MSI maps bone-derived protein changes that extend beyond visible cartilage damage 

The Analytical Scientist

March 02, 2026

Machine Learning May Help Refine Fracture Risk Prediction

"Machine learning should be used to identify postmenopausal women at increased risk of fractures."

Conexiant

February 25, 2026

Upadacitinib and Pain in RA, PsA

Mediation analysis suggests direct and indirect effects on pain reduction in rheumatoid and psoriatic arthritis.

Conexiant

February 24, 2026

Can CT Radiomics Detect Osteoporosis?

Radiomics analysis of lumbar spine computed tomography is compared with established imaging-based measures of bone density.

Conexiant

February 23, 2026

Sleep Disruption and Osteoarthritis Risk

Investigators find that short sleep, insomnia, and night shift work are associated with increased risk of knee and hip osteoarthritis and joint replacement.

Conexiant